APPLICATION
ANDA040911
TYPE
ANDA
ORIGINAL APPROVAL
2011-05-23
LATEST ACTION
2018-11-02
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription
Products
LIDOCAINEPrescription
LIDOCAINE 5% · OINTMENT · TOPICAL
Approval history
2018-11-02Labeling · Supplement 7 · standardAP
2018-11-01Labeling · Supplement 5 · standardAP
2011-05-23OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.